349 related articles for article (PubMed ID: 18550537)
1. Aberrant interaction between Parkinson disease-associated mutant UCH-L1 and the lysosomal receptor for chaperone-mediated autophagy.
Kabuta T; Furuta A; Aoki S; Furuta K; Wada K
J Biol Chem; 2008 Aug; 283(35):23731-8. PubMed ID: 18550537
[TBL] [Abstract][Full Text] [Related]
2. Insights into links between familial and sporadic Parkinson's disease: physical relationship between UCH-L1 variants and chaperone-mediated autophagy.
Kabuta T; Wada K
Autophagy; 2008 Aug; 4(6):827-9. PubMed ID: 18635949
[TBL] [Abstract][Full Text] [Related]
3. Influence of microRNA deregulation on chaperone-mediated autophagy and α-synuclein pathology in Parkinson's disease.
Alvarez-Erviti L; Seow Y; Schapira AH; Rodriguez-Oroz MC; Obeso JA; Cooper JM
Cell Death Dis; 2013 Mar; 4(3):e545. PubMed ID: 23492776
[TBL] [Abstract][Full Text] [Related]
4. Age-dependent accumulation of oligomeric SNCA/α-synuclein from impaired degradation in mutant LRRK2 knockin mouse model of Parkinson disease: role for therapeutic activation of chaperone-mediated autophagy (CMA).
Ho PW; Leung CT; Liu H; Pang SY; Lam CS; Xian J; Li L; Kung MH; Ramsden DB; Ho SL
Autophagy; 2020 Feb; 16(2):347-370. PubMed ID: 30983487
[TBL] [Abstract][Full Text] [Related]
5. Aberrant molecular properties shared by familial Parkinson's disease-associated mutant UCH-L1 and carbonyl-modified UCH-L1.
Kabuta T; Setsuie R; Mitsui T; Kinugawa A; Sakurai M; Aoki S; Uchida K; Wada K
Hum Mol Genet; 2008 May; 17(10):1482-96. PubMed ID: 18250096
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of UCHL1 modulation on alpha-synuclein in PD-like models of alpha-synucleinopathy.
Cartier AE; Ubhi K; Spencer B; Vazquez-Roque RA; Kosberg KA; Fourgeaud L; Kanayson P; Patrick C; Rockenstein E; Patrick GN; Masliah E
PLoS One; 2012; 7(4):e34713. PubMed ID: 22514658
[TBL] [Abstract][Full Text] [Related]
7. Effects of UCH-L1 on alpha-synuclein over-expression mouse model of Parkinson's disease.
Yasuda T; Nihira T; Ren YR; Cao XQ; Wada K; Setsuie R; Kabuta T; Wada K; Hattori N; Mizuno Y; Mochizuki H
J Neurochem; 2009 Feb; 108(4):932-44. PubMed ID: 19141079
[TBL] [Abstract][Full Text] [Related]
8. Familial Mutations and Post-translational Modifications of UCH-L1 in Parkinson's Disease and Neurodegenerative Disorders.
Lee YC; Hsu SD
Curr Protein Pept Sci; 2017; 18(7):733-745. PubMed ID: 26899237
[TBL] [Abstract][Full Text] [Related]
9. Membrane-associated farnesylated UCH-L1 promotes alpha-synuclein neurotoxicity and is a therapeutic target for Parkinson's disease.
Liu Z; Meray RK; Grammatopoulos TN; Fredenburg RA; Cookson MR; Liu Y; Logan T; Lansbury PT
Proc Natl Acad Sci U S A; 2009 Mar; 106(12):4635-40. PubMed ID: 19261853
[TBL] [Abstract][Full Text] [Related]
10. The lysosomal membrane protein LAMP2A promotes autophagic flux and prevents SNCA-induced Parkinson disease-like symptoms in the Drosophila brain.
Issa AR; Sun J; Petitgas C; Mesquita A; Dulac A; Robin M; Mollereau B; Jenny A; Chérif-Zahar B; Birman S
Autophagy; 2018; 14(11):1898-1910. PubMed ID: 29989488
[TBL] [Abstract][Full Text] [Related]
11. UCH-L1 aggresome formation in response to proteasome impairment indicates a role in inclusion formation in Parkinson's disease.
Ardley HC; Scott GB; Rose SA; Tan NG; Robinson PA
J Neurochem; 2004 Jul; 90(2):379-91. PubMed ID: 15228595
[TBL] [Abstract][Full Text] [Related]
12. Parkinson's disease-associated mutations in α-synuclein and UCH-L1 inhibit the unconventional secretion of UCH-L1.
Konya C; Hatanaka Y; Fujiwara Y; Uchida K; Nagai Y; Wada K; Kabuta T
Neurochem Int; 2011 Aug; 59(2):251-8. PubMed ID: 21693148
[TBL] [Abstract][Full Text] [Related]
13. Lysosomal degradation of alpha-synuclein in vivo.
Mak SK; McCormack AL; Manning-Bog AB; Cuervo AM; Di Monte DA
J Biol Chem; 2010 Apr; 285(18):13621-9. PubMed ID: 20200163
[TBL] [Abstract][Full Text] [Related]
14. Chaperone-mediated autophagy markers in Parkinson disease brains.
Alvarez-Erviti L; Rodriguez-Oroz MC; Cooper JM; Caballero C; Ferrer I; Obeso JA; Schapira AH
Arch Neurol; 2010 Dec; 67(12):1464-72. PubMed ID: 20697033
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C Virus NS5A Protein Promotes the Lysosomal Degradation of Hepatocyte Nuclear Factor 1α via Chaperone-Mediated Autophagy.
Matsui C; Deng L; Minami N; Abe T; Koike K; Shoji I
J Virol; 2018 Jul; 92(13):. PubMed ID: 29695419
[TBL] [Abstract][Full Text] [Related]
16. Parkin-mediated K63-polyubiquitination targets ubiquitin C-terminal hydrolase L1 for degradation by the autophagy-lysosome system.
McKeon JE; Sha D; Li L; Chin LS
Cell Mol Life Sci; 2015 May; 72(9):1811-24. PubMed ID: 25403879
[TBL] [Abstract][Full Text] [Related]
17. GSM-900MHz at low dose temperature-dependently downregulates α-synuclein in cultured cerebral cells independently of chaperone-mediated-autophagy.
Terro F; Magnaudeix A; Crochetet M; Martin L; Bourthoumieu S; Wilson CM; Yardin C; Leveque P
Toxicology; 2012 Feb; 292(2-3):136-44. PubMed ID: 22185909
[TBL] [Abstract][Full Text] [Related]
18. Chaperone-mediated autophagy is defective in mucolipidosis type IV.
Venugopal B; Mesires NT; Kennedy JC; Curcio-Morelli C; Laplante JM; Dice JF; Slaugenhaupt SA
J Cell Physiol; 2009 May; 219(2):344-53. PubMed ID: 19117012
[TBL] [Abstract][Full Text] [Related]
19. The effect of Parkinson's-disease-associated mutations on the deubiquitinating enzyme UCH-L1.
Andersson FI; Werrell EF; McMorran L; Crone WJ; Das C; Hsu ST; Jackson SE
J Mol Biol; 2011 Mar; 407(2):261-72. PubMed ID: 21251915
[TBL] [Abstract][Full Text] [Related]
20. The role of chaperone-mediated autophagy in neurotoxicity induced by alpha-synuclein after methamphetamine exposure.
Sun L; Lian Y; Ding J; Meng Y; Li C; Chen L; Qiu P
Brain Behav; 2019 Aug; 9(8):e01352. PubMed ID: 31286692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
